10
Participants
Start Date
February 10, 2025
Primary Completion Date
March 31, 2030
Study Completion Date
February 28, 2035
177Lu-PNT2002
"10 patients will undergo DCFPyL PET/CT and 177Lu-PSMA dosimetry imaging only (single tracer dose).~If opened, Cohort 2 patients will receive 4 cycles, every 8 weeks of 177Lu-PSMA infusion. Other procedures during treatment and follow up may include: physical exam, CT/MRI, PSMA-PET, blood draws, adverse event assessment, and completion of questionnaires."
RECRUITING
Johns Hopkins Hospital, Baltimore
Adenoid Cystic Carcinoma Research Foundation
OTHER
Progenics Pharmaceuticals, Inc.
INDUSTRY
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OTHER